Medicare Enrolled
Dr. Dexter Estrada, M.D.
Hematology & Oncology · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Estrada from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Estrada?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Estrada
Dr. Dexter Estrada is a hematology & oncology specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Estrada performed 546,939 Medicare services across 9,059 unique beneficiaries.
Between the years covered by Open Payments, Dr. Estrada received a total of $8,125 from 56 pharmaceutical and/or device companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Estrada is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in CA
$8,125 industry payments
Medicare Practice Summary
Medicare Utilization ↗546,939
Medicare services
Top 0% in CA for hematology & oncology
9,059
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~28,786 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
203,250 | $1 | $9 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
78,700 | $2 | $12 |
| Nivolumab injection (Opdivo) | 56,480 | $24 | $72 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
25,426 | $0 | $8 |
| Denosumab injection (Prolia/Xgeva) | 24,240 | $19 | $51 |
| Filgrastim-ayow biosimilar injection, 1 microgram An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram. |
22,440 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 18,070 | $1 | $11 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
14,480 | $36 | $117 |
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
12,100 | $0 | $8 |
| Injection, granisetron, extended-release, 0.1 mg | 9,700 | $5 | $20 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
9,504 | $26 | $88 |
| Iron infusion (Monoferric) | 5,400 | $16 | $62 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,375 | $0 | $1 |
| Paclitaxel chemotherapy injection | 4,352 | $0 | $8 |
| Injection, atezolizumab, 10 mg | 4,200 | $64 | $196 |
| Rituximab-arrx biosimilar injection, 10 mg An injection of rituximab-arrx, a biosimilar medication, administered in a 10 mg dose. |
4,020 | $35 | $185 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
3,700 | $0 | $9 |
| Pembrolizumab injection (Keytruda) | 3,600 | $43 | $127 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,086 | $0 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,965 | $8 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,856 | $8 | $11 |
| Lanreotide injection, 1 mg A 1 mg injection of lanreotide medication administered into the body. |
2,280 | $44 | $172 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
2,245 | $10 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,097 | $98 | $418 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
1,880 | $33 | $225 |
| Bevacizumab-maly biosimilar injection, 10 mg An injection of bevacizumab-maly, a biosimilar medication, with a dosage of 10 mg. |
1,840 | $57 | $185 |
| Injection, leucovorin calcium, per 50 mg | 1,783 | $3 | $13 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,659 | $11 | $40 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,360 | $1 | $10 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
1,247 | $20 | $64 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
1,224 | $2 | $10 |
| Iron level test | 1,065 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
1,065 | $9 | $22 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
1,061 | $13 | $35 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
825 | $24 | $88 |
| Leuprolide injectable, camcevi, 1 mg | 798 | $71 | $222 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
668 | $53 | $197 |
| Pegfilgrastim-fpgk biosimilar injection, 0.5 mg An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg. |
660 | $274 | $853 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
646 | $1 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
574 | $111 | $400 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
469 | $8 | $22 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 414 | $3 | $14 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
394 | $1 | $9 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
322 | $17 | $61 |
| Injection, potassium chloride, per 2 meq | 310 | $0 | $1 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 309 | $285 | $898 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
303 | $9 | $23 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
300 | $1 | $2 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
295 | $1,358 | $4,921 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
294 | $24 | $84 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
277 | $6 | $16 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 272 | $20 | $53 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
266 | $19 | $48 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
244 | $96 | $252 |
| PSA test (prostate cancer screening) | 226 | $18 | $46 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
219 | $16 | $42 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
216 | $4 | $11 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
210 | $142 | $558 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
204 | $69 | $286 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
203 | $55 | $194 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
175 | $13 | $47 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
169 | $2 | $12 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
157 | $16 | $41 |
| Electrophoresis laboratory test A laboratory testing technique that separates molecules based on their size and electrical charge. |
147 | $60 | $154 |
| New patient office visit, complex (60-74 min) | 139 | $170 | $594 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
119 | $110 | $410 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
107 | $28 | $90 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
95 | $17 | $59 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
87 | $3 | $9 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
86 | $50 | $145 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
82 | $32 | $307 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
81 | $4 | $14 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
80 | $71 | $153 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 75 | $140 | $502 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
74 | $15 | $38 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
54 | $62 | $193 |
| Injection, alteplase recombinant, 1 mg | 54 | $69 | $220 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
53 | $59 | $222 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
48 | $140 | $521 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
48 | $3,633 | $9,900 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
43 | $4 | $10 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
32 | $261 | $943 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
32 | $4 | $12 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 32 | $13 | $36 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
29 | $102 | $628 |
| Coagulation assessment blood test A blood test that measures how long it takes for blood to clot. The sample can be plasma or whole blood. |
29 | $6 | $16 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
27 | $109 | $480 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
24 | $80 | $306 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
23 | $1,354 | $4,921 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
19 | $4 | $11 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
14 | $20 | $62 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
13 | $51 | $149 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
12 | $140 | $639 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $52 | $248 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.6% high complexity
54.7% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,125
Total received (2018-2024)
Avg $1,161/year across 7 years
Top 35% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
411
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,278 (89.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$847 (10.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,601
2023
$1,288
2022
$1,389
2021
$1,384
2020
$801
2019
$1,453
2018
$211
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$253
Celgene Corporation
$193
ABBVIE INC.
$175
Novartis Pharmaceuticals Corporation
$145
Daiichi Sankyo Inc.
$116
SEAGEN INC.
$100
Exelixis Inc.
$91
SpringWorks Therapeutics, Inc.
$81
PFIZER INC.
$71
E.R. Squibb & Sons, L.L.C.
$59
Lilly USA, LLC
$54
SOBI, INC
$48
AstraZeneca Pharmaceuticals LP
$41
Ipsen Biopharmaceuticals, Inc
$34
Gilead Sciences, Inc.
$27
Merck Sharp & Dohme LLC
$26
BeiGene USA, Inc.
$20
Sirtex Medical Inc
$20
Genentech USA, Inc.
$18
Pharmacosmos Therapeutics Inc.
$16
SERVIER PHARMACEUTICALS LLC
$14
Top 3 companies account for 38.8% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,314
GlaxoSmithKline, LLC.
$796
Celgene Corporation
$766
Novartis Pharmaceuticals Corporation
$410
Exelixis Inc.
$288
AstraZeneca Pharmaceuticals LP
$279
Kite Pharma, Inc.
$253
AVEO Pharmaceuticals, Inc.
$253
Daiichi Sankyo Inc.
$247
Alexion Pharmaceuticals, Inc.
$225
Ipsen Biopharmaceuticals, Inc
$190
Gilead Sciences, Inc.
$179
ABBVIE INC.
$175
Sirtex Medical Inc
$174
Genentech USA, Inc.
$157
Cardinal Health 108, LLC
$152
Medtronic USA, Inc.
$142
Janssen Biotech, Inc.
$132
Pharmacyclics LLC, An AbbVie Company
$128
Amgen Inc.
$127
Lilly USA, LLC
$108
SEAGEN INC.
$100
SANOFI-AVENTIS U.S. LLC
$100
Astellas Pharma US Inc
$100
Medtronic, Inc.
$98
PFIZER INC.
$86
TerSera Therapeutics LLC
$84
SpringWorks Therapeutics, Inc.
$81
Regeneron Healthcare Solutions, Inc.
$78
GENZYME CORPORATION
$72
Pharmacyclics LLC, an AbbVie Company
$70
SOBI, INC
$69
Merck Sharp & Dohme LLC
$63
Dova Pharmaceuticals
$56
Seagen Inc.
$55
Karyopharm Therapeutics Inc.
$52
BeiGene USA, Inc.
$49
Merck Sharp & Dohme Corporation
$44
Takeda Pharmaceuticals U.S.A., Inc.
$39
Pharmacosmos Therapeutics Inc.
$31
Acrotech Biopharma LLC
$28
Myovant Sciences Inc.
$24
ImmunoGen, Inc.
$24
EMD Serono, Inc.
$23
AbbVie Inc.
$23
JAZZ PHARMACEUTICALS INC.
$23
PharmaEssentia USA Corporation
$22
MorphoSys, US Inc.
$20
Eisai Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Stemline Therapeutics Inc.
$16
Deciphera Pharmaceuticals Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
TESARO, Inc.
$12
Sobi, Inc
$12
Advanced Accelerator Applications
$11
Top 3 companies account for 35.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · BELEODAQ · BESREMI · BLENREP · BRUKINSA · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · Elahere · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · IBRANCE · IMBRUVICA · INJECTAFER · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · Neulasta · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · Onivyde · Orserdu · PADCEV · PLUVICTO · Phesgo · Pomalyst · QINLOCK · REBLOZYL · Revlimid · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SYNCHROMEDII · Stivarga · TABRECTA · TAGRISSO · TALZENNA · TECENTRIQ · TUKYSA · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VONJO · VOTRIENT · VYXEOS · Vanflyta · XGEVA · XPOVIO · YERVOY · Yescarta · ZEJULA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
28
Per 100K population
2.8
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Estrada is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Estrada experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Estrada performed 203,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Estrada receive payments from pharmaceutical companies?
Yes. Dr. Estrada received a total of $8,125 from 56 companies across 411 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Estrada's costs compare to other hematology & oncology specialists in Fresno?
Dr. Estrada's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Estrada) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fresno
Browse hematology & oncology specialists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology